AMD Archives - Journal for Clinical Studies

Current Edition

Regional News

FDA greenlights Genentech’s eye implant for macular degeneration. Will it be a tough sell?

Two treatments per year as opposed to 12, what’s not to like? In two words—surgical implants. That’s the stigma Genentech will potentially face as it attempts to con...

26 October 2021 Regional News age-related macular degeneration | AMD

Continue Reading →

Europe

Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing nove...

4 July 2018 Europe AMD | clinical

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Vaccine – Shorten Start-Up Timelines in Vaccine Trials

Current Edition

FDA greenlights Genentech’s eye implant for macular degeneration. Will it be a tough sell?

Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment

Journal for Clinical Studies